NCT04542694.

Study characteristics
Methods	Open‐label RCT
Participants	People with moderate COVID‐19 disease
Interventions	Favipiravir, standard of care
Outcomes	Rate and time to clinical improvement Rate of viral elimination by Day 10 Time before end of fever Change in the level of lung damage according to CT (time frame: days 15, 21, 28). Assessment of lung injury: degree of damage by "empirical" visual scale and % of patients) according to CT data compared to baseline. The number of patients in whom, by the end of therapy, there was an improvement in the condition of the lungs (a decrease in the volume of the lesion according to CT). Rate of transfer to the ICU Rate of the use of non‐invasive lung ventilation (i.e. percentage of cases with non‐invasive lung ventilation (% of patients)) Rate of the use of mechanical ventilation (percentage of cases with mechanical lung ventilation (% of patients)) Mortality (incidence of fatal cases (% of patients))
Notes